ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "arthritis management"

  • Abstract Number: 2572 • 2015 ACR/ARHP Annual Meeting

    Protective and Therapeutic Effects of Growth Hormone on Collagen-Induced Arthritis

    Ricardo J. Villares1, Gabriel Criado2, Rosa P Gomariz3, Yasmina Juarranz3, Javier Leceta3, Graciela Cascio4, Jose L. Pablos5 and Mario Mellado6, 1Immunology & Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain, 2Servicio de Reumatología, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain, 3Cellular Biology, School of Biology. Universidad Complutense de Madrid, Madrid, Spain, 4Immunoloy & Oncology, Centro Nacional de Biotecnología-CSIC, Madrid, Spain, 5Instituto de Investigacion Hospital, Madrid, Spain, 6Immunology and Oncology, Centro Nacional de Biotecnología. CNIC, Madrid, Spain

    Background/Purpose: Inflammatory (M1) macrophages and T helper 17 (TH17) cells are central to rheumatoid arthritis (RA) pathogenesis.  Although the growth hormone [GH]/insulin-like growth factor 1…
  • Abstract Number: 2875 • 2015 ACR/ARHP Annual Meeting

    Anti-TNF Therapy  Is Not Associated with an Increase in Neoplasias in Patients with Spondyloarthritis (SpA): Results from the GISEA Registry

    Fabiola Atzeni1, Antonio Carletto2, Marco Sebastiani3, Valentina Panetta4, Fausto Salaffi5, Florenzo Iannone6, Elisa Gremese7, Marcello Govoni8, Antonio Marchesoni9, Roberto Gorla10, Roberta Ramonda11, Pier Carlo Sarzi-Puttini12, Gianfranco Ferraccioli7, Giovanni Lapadula13 and on behalf of GISEA group, 1Rheumatology Unit, L. Sacco University Hospital of Milan, Milan, Italy, 2Rheumatology Unit, University of Verona, Verona, Italy, 3SC Reumatologia, Dipartimento di Medicine, Medicina d’Urgenza e Specialità Mediche, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy, 4L'altrastatistica -Consultancy & Training- Biostatistics office., Rome, Italy, 5Rheumatology Department, Polytechnic University of Marche, C. Urbani Hospital, Jesi,, Ancona, Italy, 6Interdisciplinary Department of Medicine (DIM), Rheumatology Unit, University of Bari, Bari, Italy, 7Division of Rheumatology, Institute of Rheumatology, Catholic University of the Sacred Heart, Rome, Italy, 8Department of Medical Sciences, UOC of Rheumatology, Azienda Ospedaliero-Universitaria S. Anna-Ferrara, University of Ferrara, Cona Ferrara, Italy, 9Rheumatology Unit, Orthopedic Institute G. Pini, Milano, Italy, 10Rheumatology and Immunology Unit, Spedali Civili di Brescia, Brescia, Italy, 11Cattedra, Voc Rheumatology, University of Padua, Padova, Italy, 12Rheumatology Unit, L. Sacco University Hospital, Milan, Italy, 13Bari University, Rheumatology, Bari, Italy

    Background/Purpose: The use of TNF inhibitors (TNFIs) has led to efficient control of the signs and symptoms of SpA and rheumatoid arthritis (RA), and significantly…
  • Abstract Number: 1193 • 2015 ACR/ARHP Annual Meeting

    The Effectiveness of Low-Impact Exercise Program on Musculoskeletal Health of Asian Older Adults

    Huijuan Huang1, Titilayo Ologhobo1, Vicky Jin1, Sandra Goldsmith2 and Laura Robbins1, 1Education & Academic Affairs, Hospital for Special Surgery, New York, NY, 2Public and Patient Education, Hospital for Special Surgery, New York, NY

    Background/Purpose: The Center for Disease Control and Prevention (CDC) showed that in 2010-2015, 50% of adults 65 years or older reported an arthritis diagnosis. Studies…
  • Abstract Number: 1405 • 2015 ACR/ARHP Annual Meeting

    Tocilizumab Serum Levels and Antidrug Antibodies and Its Relationship with Disease Activity in Rheumatic Diseases

    Samantha Rodriguez-Muguruza1, Melania Martínez-Morillo1, Juana Sanint2, Bibiana Quirant Sr.3, Aina Teniente Sr.4, Agueda Prior5, Anne Riveros-Frutos6, Susana Holgado7, Maria Lourdes Mateo7, Alejandro Olivé8, Jeronima Cañellas5 and Xavier Tena7, 1Rheumatology, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain, 2Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, 3Immunology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, 4immunology, Hospital Universitari Germans Trias i Pujol, barcelona, Spain, 5Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, 6Microbiology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, 7Rheumatology, Hospital Germans Trias i Pujol, Badalona, Spain, 8Hospital Germans Trias i Pujol, Badalona, Spain

    Background/Purpose: Tocilizumab (TCZ) is a humanized anti-IL-6 receptor-blocking monoclonal antibody used for the treatment of rheumatoid arthritis (RA), idiopathic juvenile arthritis (IJA) and off-label in…
  • Abstract Number: 1495 • 2015 ACR/ARHP Annual Meeting

    Person-Centred Care Can Help Patients to Become More Effective Consumers in the Use of Health Information Than Regular Care – an RCT in Patients with Arthritis Undergoing Biological Therapy

    Ingrid Larsson1,2, Stefan Bergman2,3,4 and Ann Bremander2,3,5, 1School of Health and Welfare, Halmstad University, Halmstad, Sweden, 2FoU Spenshult, Halmstad, Sweden, 3Department of Clinical Sciences, Lund, Section of Rheumatology, Lund University, Lund, Sweden, 4Primary Health Care Unit, Department of Public Health and Community Medicine, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 5School of Business, Engineering and Science, Halmstad University, Halmstad, Sweden

    Background/Purpose: Person-centred care (PCC) is a holistic approach with respectful and individualized care allowing negotiation of care where persons with health problems are empowered to…
  • Abstract Number: 2873 • 2013 ACR/ARHP Annual Meeting

    The Ion Channel TRPV2 Is New Suppressor of Arthritis Severity and Joint Damage

    Teresina Laragione1,2, Max Brenner1,2, Christine Beeton3 and Percio Gulko1,2, 1Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, 2Molecular Medicine, Hosftra North Shore-LIJ School of Medicine, Manhasset, NY, 3Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX

    Background/Purpose: Rheumatoid arthritis (RA) is a common and chronic disease associated with increased risk of developing disability. Disease remission is still rarely achieved and better…
  • Abstract Number: 2843 • 2013 ACR/ARHP Annual Meeting

    An Education Needs Assessment: Findings From Surveys Of Patients and Caregivers

    Elizabeth M. Badley1,2, Monique A. Gignac2,3,4, Lynn Moore5, Christina H. Chan6, Xingshan Cao7 and Julie Bowring8, 1Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 2Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada, 3Institute for Work and Health, Toronto, ON, Canada, 4Divison of Health Care & Outcomes Research, University Health Network, Toronto, ON, Canada, 5Programs and Services, The Arthritis Society, Toronto, ON, Canada, 6Division of Healthcare Outcomes and Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 7Divison of Health Care & Outcomes Research, Arthritis Community Research and Evaluation Unit , Toronto Western Research Institute, Toronto, ON, Canada, 8Arthritis Community Research and Evaluation Unit, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada

    Background/Purpose: Getting trustworthy information to patients with arthritis is a challenge facing health professionals and organizations concerned with arthritis. This study examined the perceptions of…
  • Abstract Number: 2718 • 2013 ACR/ARHP Annual Meeting

    Exploring E-Health Ethics and Multi-Morbidity: A Qualitative Study Of Patient and Clinician Experiences Using Digital Media For Health Purposes

    Anne F. Townsend1,2,3,4, Paul M Adam5, Linda C. Li6,7, Jenny Leese1, Michael McDonald8, Sheila Kerr9, Gordon Whitehead10 and Catherine L. Backman11, 1Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 2Occupational Science and Occupational Therapy, University of British Columbia, Vancouver, BC, Canada, 3Qualitative Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, 4University of British Columbia, Vancouver, BC, Canada, 5Rheumatology Liaison, Mary Pack Arthritis Centre, Vancouver, BC, Canada, 6Physical Therapy, University of British Columbia, Vancouver, BC, Canada, 7Physical Therapy, Arthritis Centre of Canada, Richmond, BC, Canada, 8Maurice Young Centre for Applied Ethics, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, 9Arthritis Patient Advisory Board, Richmond, BC, Canada, 10Consumer Advisory Board, Vancouver, BC, Canada, 11Arthritis Research Centre of Canada, Richmond, BC, Canada

    Background/Purpose: E-Health can potentially transform and enhance health care delivery and empower patients. E-health includes a spectrum of digital health services and information communicated through…
  • Abstract Number: 2240 • 2013 ACR/ARHP Annual Meeting

    Correlative Analysis Of Swollen Joints Between Clinical Examination and Musculoskeletal Ultrasound For Rheumatoid Arthritis

    Kenta Misaki1, Takashi Nakazawa2, Shunichi Fujita1, Hirotaka Yamada1 and Toshihiko Yokota1, 1Rheumatology, Kurashiki Central Hospital, Kurashiki, Japan, 2Rheumatology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan

    Background/Purpose: The disease activity score 28 (DAS28), clinical disease activity index (CDAI) and simplified disease activity index (SDAI) are all used in the clinical assessment…
  • Abstract Number: 2218 • 2013 ACR/ARHP Annual Meeting

    Gingival Stem Cells Suppress Osteoclast Formation and Bone Erosion In CIA Through CD39 Signal

    Song Guo Zheng1, Jian Gu2, Maogeng Chen1 and Yi Shen3, 1Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, 2Medcine, University of Southern California Keck School of Medicine, Los Angeles, CA, 3Medicine, Shanghai East Hospital at Tongji University, Shanghai, China

    Background/Purpose: We recently have reported that human-derived gingival mesenchymal stem cells (GMSC) have strong capacity to suppress immune responses and T cell-mediated collagen-induced arthritis, however,…
  • Abstract Number: 2015 • 2013 ACR/ARHP Annual Meeting

    Sarcoid Arthritis In World Trade Center Exposed New York City Firefighters Presenting As a Unique Clinical Subset

    Konstantinos Loupasakis1, Jessica Berman2, Michelle S Glaser3,4, Nadia Jaber4, Rachel Zeig-Owens3,4, Mayris P Webber4,5, Michael D Weiden4,6, Anna Nolan4,7, Kerry J Kelly4 and David J Prezant4,8, 1Rheumatology, Hospital for Special Surgery Weill Cornell Medical College, New York, NY, 2Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 3Medicine, Montefiore Medical Center, Bronx, NY, 4Bureau of Health Services Fire Department of New York, Brooklyn, NY, 5Medicine and Epideiology and Population Health, Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY, 6Pulmonary, Critical Care and Sleep Medicine, New York University School of Medicine, New York, NY, 7Medicine, New York University School of Medicine, New York, NY, 8Montefiore Medical Center Albert Einstein College of Medicine, Bronx, NY

    Background/Purpose: Sarcoidosis is a multisystem disease characterized by the formation of non-caseating granulomas with lungs being predominantly affected and the joints in up to 40%.…
  • Abstract Number: 1931 • 2013 ACR/ARHP Annual Meeting

    Models Of Care For Arthritis: Drivers, Facilitators and Barriers To Their Development and Implementation

    Aileen M. Davis1, Cheryl Cott2, Rose Wong3, Michel Landry4, Linda Li5, Allyson Jones6, Cy Frank7, Sydney C. Lineker8, Louise Bergeron9, Gillian A. Hawker10, Dianne P. Mosher11, Vandana Ahluwalia12, Michel Zummer13, Susan B. Jaglal14, Rhona McGlasson15, Richard Birtwhistle16, Sherry Bar17 and Elizabeth M. Badley18, 1Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Ontario, ON, Canada, 2Divison of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 3Division of Health Care & Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 4Department of Community and Family Medicine, Physical Therapy Division, Duke University Medical Center, Durham, NC, 5Arthritis Centre of Canada and Department of Physical Therapy, University of British Columbia, Vancouver, BC, Canada, 6Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, 7Alberta Bone and Joint Institute and Department of Surgery, University of Calgary, Calgary, AB, Canada, 8The Arthritis Society, Toronto, ON, Canada, 9Canadian Arthritis Patient Alliance, Ottawa, ON, Canada, 10Women's College Research Institute, University of Toronto, Toronto, ON, Canada, 11Med, University of Calgary, Calgary, AB, Canada, 12Past President, Ontario Rheumatology Association, Brampton, ON, Canada, 13Rheumatology, Ch Maisonneuve-Rosemont, Montreal, QC, Canada, 14Department of Physical Therapy, Department of Physical Therapy, University of Toronto, Toronto, ON, Canada, 15Bone and Joint Canada, Toronto, ON, Canada, 16Centre for Studies in Primary Care and Family Medicine and Community Health and Epidemiology, Queen's University, Kingston, ON, Canada, 17British Columbia Ministry of Health Services, Victoria, BC, Canada, 18Division of Health Care and Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada

    Background/Purpose: Management of arthritis is a growing concern given disease prevalence and limited health care resources. In the context of a larger project investigating innovative…
  • Abstract Number: 1586 • 2013 ACR/ARHP Annual Meeting

    Defining Hand Arthritis In Systemic Lupus Erythematosus, From An Ultrasound, Magnetic Resonance Imaging and Antibody Status Perspective

    Elisabeth M.A Ball1, Arthur Grey2, Ai Lyn Tan3, Eiji Fukuba4, Gunter Steiner5, Dennis McGonagle6, Aubrey Bell7 and Madeleine Rooney8, 1Rheumatology, Queens' University/Musgrave Park Hospital, Belfast, United Kingdom, 2Rheumatology, Musgrave Park Hospital, Belfast, United Kingdom, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 4Department of Radiology, Shimane University, Izuma, Japan, 5Internal Medicine III, Division of Rheumatology, Medical University of Vienna, Vienna, Austria, 6NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom, 7Rheumatology Unit, Musgrave Park Hospital, Belfast, United Kingdom, 8Medicine, Queens University Belfast, Belfast, United Kingdom

    Background/Purpose: Musculoskeletal involvement in systemic lupus erythematosus (SLE) is common but poorly characterised with only a few Magnetic Resonance Imaging (MRI) or ultrasound (US) studies…
  • Abstract Number: 1279 • 2013 ACR/ARHP Annual Meeting

    Anti-IL-6 Receptor Antibody Is Effective In Arthritis Regardless Of Obesity In Mouse Model

    Miho Suzuki, Hiroto Yoshida and Yoshihiro Matsumoto, Product Research Department, Chugai Pharmaceutical Co., Ltd., Gotemba, Japan

    Background/Purpose: Compared with non-obese patients, obese patients with rheumatoid arthritis (RA) reportedly experience worsening of symptoms [Arthritis Care Res (Hoboken). 2013; 65: 78-87] and do…
  • Abstract Number: 1139 • 2013 ACR/ARHP Annual Meeting

    Pyogenic Arthritis: Clinical and Epidemiological Features Of 101 Cases At a University Hospital

    Anne Riveros-Frutos1, Lourdes Mateo1, Melania Martínez-Morillo2, Beatriz Tejera3, Samantha Rodriguez-Muguruza1, Juana Sanint1, Susana Holgado1, Jerónima Cañellas1, Xavier Tena1, Alejandro Olivé1 and Montserrat Gímenez4, 1Rheumatology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain, 2Rheumatology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain, 3Rheumatology, University Hospital of Canary Islands, Santa Cruz de Tenerife, Spain, 4Microbiology, Hospital Universitario Germans Trias i Pujol, Badalona, Spain

    Background/Purpose:  To describe the clinical characteristics, treatment and outcome of patients diagnosed with pyogenic septic arthritis. Methods:  Design: retrospective (1984-2012). Location: University hospital. Referial area:…
  • « Previous Page
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology